SG
OSCR icon

StoneX Group’s Oscar Health OSCR Stock Holding History

StoneX Group’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,850
Closed -$254K – 993
2025
Q2 		$254K Buy
+11,850
New +$176K 0.01% 708

Other funds holding OSCR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

StoneX Group's OSCR Position: Q3 2025 in Review

StoneX Group sold out of Oscar Health (OSCR) in Q3 2025, closing a stake of 11,850 shares — an estimated $254K sold.

StoneX Group first reported a position in OSCR in Q2 2025 and held it in 1 quarter. The position peaked at $254K in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q3 2025.

  • StoneX Group reported no remaining Oscar Health position as of Q3 2025 after selling out during the quarter.
  • StoneX Group sold 11,850 Oscar Health shares in Q3 2025, an estimated $254K.
  • StoneX Group first reported a position in Oscar Health in Q2 2025 and held it in 1 quarter.
  • StoneX Group's Oscar Health position peaked at $254K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Oscar Health as of Q3 2025.

Based on StoneX Group's 13F filing for Q3 2025, filed 14 Nov 2025.